Cargando…

The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival

This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggers, Paul W., Connerton, Rose, McMullan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1984
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191361/
https://www.ncbi.nlm.nih.gov/pubmed/10310599
_version_ 1782338646781722624
author Eggers, Paul W.
Connerton, Rose
McMullan, Michael
author_facet Eggers, Paul W.
Connerton, Rose
McMullan, Michael
author_sort Eggers, Paul W.
collection PubMed
description This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for black people is 2.8 times that of white people. Incidence is highest for persons 65 to 69 years of age. Total patient survival is 44 percent 5 years after renal failure onset. Total Medicare enrollment for ESRD quadrupled between the years 1974 and 1981.
format Online
Article
Text
id pubmed-4191361
institution National Center for Biotechnology Information
language English
publishDate 1984
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41913612014-11-04 The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival Eggers, Paul W. Connerton, Rose McMullan, Michael Health Care Financ Rev Research Article This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for black people is 2.8 times that of white people. Incidence is highest for persons 65 to 69 years of age. Total patient survival is 44 percent 5 years after renal failure onset. Total Medicare enrollment for ESRD quadrupled between the years 1974 and 1981. CENTERS for MEDICARE & MEDICAID SERVICES 1984 /pmc/articles/PMC4191361/ /pubmed/10310599 Text en
spellingShingle Research Article
Eggers, Paul W.
Connerton, Rose
McMullan, Michael
The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title_full The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title_fullStr The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title_full_unstemmed The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title_short The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
title_sort medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191361/
https://www.ncbi.nlm.nih.gov/pubmed/10310599
work_keys_str_mv AT eggerspaulw themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival
AT connertonrose themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival
AT mcmullanmichael themedicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival
AT eggerspaulw medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival
AT connertonrose medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival
AT mcmullanmichael medicareexperiencewithendstagerenaldiseasetrendsinincidenceprevalenceandsurvival